Inven2 is the next-generation innovation company, established to maintain and develop Norwegian innovations. Inven2 builds bridges between excellent research and the next generation technology based industry.
Inven2 is the largest contributor in Norway within the field of commercialization of research, owned by the University of Oslo and Oslo University Hospital, Norway’s largest and leading university and hospital representing pioneering research.
The Norwegian Radium Hospital Research Foundation (RF) invests in companies based on the continuing flow of state-of-the-art innovations from leading Nordic research institutions. RF is an independent organisation founded in 1986 by The Norwegian Radium Hospital and the Norwegian Ministry of Health. The aim of RF is to strengthen cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital.
Gjelsten Holding creates value through active ownership. We strengthen our companies by providing funding and competence.
Sundt AS is a privately owned investment company.
Watrium AS is a privately family owned investment company. We are focused on ethical values and our operations are within active, long-term ownership of a global financial portfolio, industrial assets and real estate.